Renal mechanism of trimethoprim-induced hyperkalemia

Annals of Internal Medicine

Volumn 119, Issue 4, 1993, Pages 296-301

  Velázquez, Heino ^a   Perazella, Mark A ^a   Wright, Fred S ^a   Ellison, David H ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM CHANNEL; TRIMETHOPRIM;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADRENAL CORTEX FUNCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROLYTE BLOOD LEVEL; ELECTROLYTE URINE LEVEL; GLOMERULUS FILTRATION RATE; HUMAN; HYPERKALEMIA; MALE; NONHUMAN; POTASSIUM BLOOD LEVEL; POTASSIUM EXCRETION; PRIORITY JOURNAL; RAT; SODIUM URINE LEVEL;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMAL; HUMAN; HYPERKALEMIA; KIDNEY; KIDNEY TUBULES, DISTAL; MALE; NATRIURESIS; PNEUMONIA, PNEUMOCYSTIS CARINII; POTASSIUM; RATS; RATS, SPRAGUE-DAWLEY; RETROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; TRIMETHOPRIM;

EID: 0027374903     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-119-4-199308150-00008     Document Type: Article

References (25)

1. Poretsky L, Maran A, Zumoff B. Endocrinologic and metabolic manifestations of the acquired immunodeficiency syndrome. Mt Sinai J Med. 1990;57:236-41.
2. Marks JB. Endocrine manifestations of human immunodeficiency virus (HIV) infection. Am J Med Sci. 1991;302:110-7.
3. Grinspoon SK, Bilezikian JP. HIV disease and the endocrine system. N Engl J Med. 1992;327:1360-5.
4. Kalin MF, Poretsky L, Seres DS, Zumoff B. Hyporeninemic hypoaldosteronism associated with acquired immune deficiency syndrome. Am J Med. 1987;82:1035-8.
5. Berns JS, Cohen RM, Stumacher RJ, Rudnick MR. Renal aspects of therapy for human immunodeficiency virus and associated opportunistic infections. J Am Soc Nephrol. 1991;1:1061-80.
6. Loose DS, Kan PB, Hirst MA, Marcus RA, Feldman D. Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes. J Clin Invest. 1983;71:1495-9.
7. Elansary EH, Earis JE. Rifampin and adrenal crisis. Br Med J. 1983;286:1861-2.
8. Lachaal M, Venuto RC. Nephrotoxicity and hyperkalemia in patients with acquired immunodeficiency syndrome treated with pentamidine. Am J Med. 1989;87:260-3.
9. Kaufman AM, Hellman G, Abramson RG. Renal salt wasting and metabolic acidosis with trimethoprim-sulfamethoxazole therapy. Mt Sinai J Med. 1983;50:238-9.
10. Medina I, Mills J, Leoung G, Hopewell PC, Lee B, Modin G, et al. Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprimsulfamethoxazole versus trimethoprim-dapsone. N Engl J Med. 1990;323:776-82.
11. West ML, Marsden PA, Richardson RMA, Zettle RM. New clinical approach to evaluate disorders of potassium excretion. Miner Electrolyte Metab. 1986;12:234-8.
12. Zettle RM, West ML, Josse RG, Richardson RMA, Marsden PA, Halperin ML. Renal potassium handling during states of low aldosterone bio-activity: A method to differentiate renal and non-renal causes. Am J Nephrol. 1987;7:360-6.
13. Good DW, Wright FS. Luminal influences on potassium secretion: sodium concentration and fluid flow rate. Am J Physiol. 1979;236: F192-F205.
14. Velázquez H, Wright FS, Good DW. Luminal influences on potassium secretion: chloride replacement with sulfate. Am J Physiol. 1982;242:F46-F55.
15. Good DW, Wright FS. Luminal influences on potassium secretion: transepithelial voltage. Am J Physiol. 1980;239:F289-F298.
16. Strauss KW. Endocrine complications of the acquired immunodeficiency syndrome. Arch Intern Med. 1991;151:1441-4.
17. Greenberg S, Reiser IW, Chow SY, Porush JG. Trimethoprim-sulfamethoxazole (TMP-SMX) induces reversible hyperkalemia [Abstract]. J Am Soc Nephrol. 1992;3:327-30.
18. Merenich JA, McDermott MT, Asp AA, Harrison SM, Kidd GS. Evidence of endocrine involvement early in the course of human immunodeficiency virus infection. J Clin Endocrinol Metab. 1990; 70:566-71.
19. Choi MJ, Fernandez PC, Patnask A, et al. Hyperkalemia and renal salt wasting due to the K-sparing diuretic effects of trimethoprim [Abstract]. J Am Soc Nephrol. 1992;3:325.
20. Fonseca PD, Moura TF, Ferreira KTG. The effect of trimethoprim on sodium transport across the frog skin epithelium. Eur J Pharmacol. 1991;207:337-43.
21. Okusa MD, Velázquez H, Wright FS. Effect of Na-channel blockers and lumen Ca on K secretion by rat renal distal tubule. Am J Physiol. 1991;260:F459-65.
22. Velázquez H, Wright FS. Effects of diuretic drugs on Na, Cl, and K transport by rat renal distal tubule. Am J Physiol. 1986;250:F1013-23.
23. Ellison DH, Velázquez H, Wright FS. Stimulation of distal potassium secretion by low lumen chloride in the presence of barium. Am J Physiol. 1985;248:F638-49.
24. Lee BL, Medina I, Benowitz NL, Jacob P 3d, Wofsy CB, Mills J 5th. Dapsone, trimethoprim, and sulfamethoxazole plasma levels during treatment of Pneumocystis pneumonia in patients with the acquired immuodeficiency syndrome (AIDS). Evidence of drug interactions. Ann Intern Med. 1989;110:606-11.
25. Physician's Desk Reference. Oradell: Medical Economics Company, Inc.;1992.